Bill Sponsor
Senate Bill 637
116th Congress(2019-2020)
CURE High Drug Prices Act
Introduced
Introduced
Introduced in Senate on Feb 28, 2019
Overview
Text
Introduced
Feb 28, 2019
Latest Action
Feb 28, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
637
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act

This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.

Text (1)
February 28, 2019
Actions (2)
02/28/2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
02/28/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 5:03:30 PM